(5S,2R)-Methyl 5-Decyl-2-methoxy-7-methyl-2,3,4,5-tetrahydro-1,2-oxaphosphepine-6-carboxylate 2-Oxide

ID: ALA2380756

Chembl Id: CHEMBL2380756

PubChem CID: 71682923

Max Phase: Preclinical

Molecular Formula: C19H35O5P

Molecular Weight: 374.46

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCC[C@H]1CC[P@@](=O)(OC)OC(C)=C1C(=O)OC

Standard InChI:  InChI=1S/C19H35O5P/c1-5-6-7-8-9-10-11-12-13-17-14-15-25(21,23-4)24-16(2)18(17)19(20)22-3/h17H,5-15H2,1-4H3/t17-,25+/m0/s1

Standard InChI Key:  NHTZROPHLCBBHP-SSOJOUAXSA-N

Associated Targets(non-human)

CUT1 Cutinase 1 (30 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis H37Rv (422 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacteroides abscessus (2066 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 374.46Molecular Weight (Monoisotopic): 374.2222AlogP: 5.84#Rotatable Bonds: 11
Polar Surface Area: 61.83Molecular Species: HBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 4.69CX LogD: 4.69
Aromatic Rings: Heavy Atoms: 25QED Weighted: 0.26Np Likeness Score: 0.32

References

1. Point V, Malla RK, Carrière F, Canaan S, Spilling CD, Cavalier JF..  (2013)  Enantioselective inhibition of microbial lipolytic enzymes by nonracemic monocyclic enolphosphonate analogues of cyclophostin.,  56  (11): [PMID:23651298] [10.1021/jm4000787]
2. Cavalier JF, Spilling CD, Durand T, Camoin L, Canaan S..  (2021)  Lipolytic enzymes inhibitors: A new way for antibacterial drugs discovery.,  209  [PMID:33071055] [10.1016/j.ejmech.2020.112908]

Source